TransMedics signs agreement to invest in PAD Aviation

TransMedics (TMDX) Group announced that it has entered into a definitive agreement to invest in PAD Aviation, a premier Germany-based private aviation operator. The proposed strategic investment is intended to support TransMedics’ ongoing efforts to replicate the successful U.S. NOP and logistics model by building a dedicated organ transplantation air and ground logistics network in Europe in support of its OCS perfusion platform and clinical services, with the goal of expanding access to donor organs and increasing transplant volumes for patients in need across the European Union. The proposed strategic investment is subject to the satisfaction of closing conditions specified in the definitive agreement between the parties as well as applicable regulatory conditions. TransMedics expects the transaction to close later in 2026 but can provide no assurance that the proposed transaction will be consummated. Financial terms are not being disclosed.